This annual event appeals to global executives from companies that make up the leaders of the biotechnology and pharmaceutical industry.
Universal Medica Group invites you to join its 2nd edition of the Innovation Days,the only international lifescience event in France,at the Cite Internationale Universitaire, in Paris on September 26th & 27th 2011.
This annual event appeals to global executives from companies that make up the leaders of the biotechnology and pharmaceutical industry.
New!
Partnering Deal Sessions and Licensing Opportunities with the most suitable potential partners
Be part of this unique event and accelerate your success through innovation!
Reasons to register today:
Innovation Days 2011 Highlights:
Innovation Days agenda will include topics such as:
Key speakers:
Who will you meet? Innovation Days 2011 hosts executives from:
Price/Registration Fees:
850 Euro: Private companies
440 Euro: Academic/public institutions
Visit our website at http://lifescience-outlook.com/innovationdays2011/homepage for more detailed information and start creating your company profile!
Stay connected: Join us on LinkedIn: "Innovation Days 2011"
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.